|
|
|
|
A tribute to the greats: Pioneers defined, shaped field of dermatology
Source: Dermatology Times Email|Print| Del.icio.us Digg Reddit Facebook |Save|License 12 Key Points Pioneers in dermatology History of dermatology Classification of cutaneous diseases Throughout history, many physicians and researchers have...
|
|
|
Merkel Cell Polyomavirus in Cutaneous Squamous Cell Carcinoma of Immunocompetent Individuals
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Journal of Investigative Dermatology, 07/02/09 Print Save in My Library Free Abstract Dworkin AM et al.- All sequenced SCC samples had a common mutation...
|
|
|
Melanoma: Findings from Ghent University, Department of Dermatology broaden understanding of melanoma
Findings from Ghent University, Department of Dermatology broaden understanding of melanoma Investigators publish new data in the report 'The role of RhoC in growth and metastatic capacity of melanoma.' 'RhoC overexpression in tumor cells...
|
|
|
Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cuta
Largest clinical study ever involving patients with cutaneous T-cell lymphoma on schedule for completion in June 2010 RADNOR, Pa., June 29 /PRNewswire/ -- Yaupon Therapeutics, a privately held specialty pharmaceutical company, has announced...
|
|
|
The Association between MC1R Genotype and BRAF Mutation Status in Cutaneous Melanoma: Findings from an Austral
Elke Hacker1, Nicholas K Hayward1, Troy Dumenil1, Michael R James1 and David C Whiteman1 1Genetics & Population Health Division, Queensland Institute of Medical Research, Brisbane, Queensland, Australia Correspondence: Dr Elke Hacker...
|
|
|
Histological Characterization of Cutaneous Nerve Fibers Containing Gastrin-Releasing Peptide in NC/Nga Mice: A
1Institute for Environmental and Gender Specific Medicine, Juntendo University Graduate School of Medicine, Urayasu, Chiba, Japan 2Department of Dermatology, Ju Histological Characterization of Cutaneous Nerve Fibers Containing Gastrin...
|
|
|
Cutaneous vasoconstriction as a measure of incipient autonomic dysreflexia during penile vibratory stimulation
1Spinal Injuries Research Centre, Prince of Wales Medical Research Institute, Sydney, New South Wales, Australia 2Spinal Unit, Prince of Wales Hospital, Sydney, Cutaneous vasoconstriction as a measure of incipient autonomic dysreflexia...
|
|
|
Yaupon Completes Patient Enrollment For Phase-II Study Of Clearazide
Clearazide, for the treatment of Cutaneous T-cell Lymphoma Yaupon has completed enrollment for a pivotal phase-II clinical trial for Clearazide, for the treatment of early-stage cutaneous T-cell lymphoma (CTCL - stages 1-2a).The...
|
|
|
Yaupon Therapeutics Completes Patient Enrollment For Pivotal Phase 2 Study Of Clearazide For Treatment Of Cuta
Yaupon Therapeutics, a privately held specialty pharmaceutical company, has announced it has completed enrollment for a pivotal Phase 2 clinical trial for Clearazide for the treatment of early-stage cutaneous T-cell lymphoma (CTCL - stages 1...
|
|
|
Yaupon Therapeutics Inc. Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of
Largest clinical study ever involving patients with cutaneous T-cell lymphoma on schedule for completion in June 2010 RADNOR, Pa., June 29 /PRNewswire/ -- Yaupon Therapeutics, a privately held specialty pharmaceutical company, has announced...
|
|
|
Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cuta
Largest clinical study ever involving patients with cutaneous T-cell lymphoma on schedule for completion in June 2010 RADNOR, Pa., June 29 /PRNewswire/ -- Yaupon Therapeutics, a privately held specialty pharmaceutical company, has announced...
|
|
|
Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cuta
Largest clinical study ever involving patients with cutaneous T-cell lymphoma on schedule for completion in June 2010 RADNOR, Pa., June 29 /PRNewswire/ -- Yaupon Therapeutics, a privately held specialty pharmaceutical company, has announced...
|
|
|
Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cuta
Largest clinical study ever involving patients with cutaneous T-cell lymphoma on schedule for completion in June 2010 RADNOR, Pa., June 29 /PRNewswire/ -- Yaupon Therapeutics, a privately held specialty pharmaceutical company, has announced...
|
|
|
Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cuta
Largest clinical study ever involving patients with cutaneous T-cell lymphoma on schedule for completion in June 2010 RADNOR, Pa.The randomized, double-blind, controlled clinical study is the largest ever undertaken involving patients...
|
|
|
Yaupon Therapeutics Completes Patient Enrollment for Pivotal Phase 2 Study of Clearazide for Treatment of Cuta
Largest clinical study ever involving patients with cutaneous T-cell lymphoma on schedule for completion in June 2010 RADNOR, Pa., June 29 /PRNewswire/ -- Yaupon Therapeutics, a privately held specialty pharmaceutical company, has announced...
|
|
|
Functional RET G691S polymorphism in cutaneous malignant melanoma
1Department of Molecular Oncology, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA, USA 2Department of Anatomical Pathology, Sydney Cancer Center, Royal Prince Alfred Hospital, Camperdown, Australia 3Sydney...
|
|
|
Case: Asymptomatic eruption
On examination there are multiple palpable purpuric papules, most of which have an overlying scale/crust.No intact vesicles or bullae are noted. Differential diagnosis Conditions to consider are those that produce crusted purpuric...
|
|
|
NYU Langone Medical Center Awarded NIH Grants Totaling $1,560,000
Two NYU Langone Medical Center researchers have received $1,560,000 in grant support for their first year of studies focused on microbiome and psoriasis and on microbiome and esophageal cancer from the National Institutes of Health (NIH).
|
|
|
Case 20-2009 - A 79-Year-Old Woman with a Blistering Cutaneous Eruption
_ Case 20-2009 - A 79-Year-Old Woman with a Blistering Cutaneous Eruption.
|
|
|
Skin metastases from lung cancer
(Click the title below to leave the MDLinx Network and go to the Journal's Website) Dermatology Online Journal, 06/25/09 Print Save in My Library Free Full Text Mollet TW et al.- Cutaneous metastases from the lung, although uncommon...
|
|
|
Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib
Today in Clinical Pharmacology...Cutaneous adverse effects in patients treated with the multitargeted kinase inhibitors sorafenib and sunitinib.
|
|
|
Nestin in Human Skin: Exclusive Expression in Intramesenchymal Skin Compartments and Regulation by Leptin
1Department of Dermatology, Allergology and Venerology, University of Lbeck, Lbeck, Germany 2Fraunhofer Institute of Marine Biotechnology, Lbeck, Germany 3School of Translational Research, University of Manchester, Manchester, UK...
|
|
|
Merkel Cell Polyomavirus in Cutaneous Squamous Cell Carcinoma of Immunocompetent Individuals
1Integrated Biomedical Sciences Graduate Program, The Ohio State University, Columbus, Ohio, USA 2College of Biological Sciences, The Ohio State University, Columbus, Ohio, USA 3Clinical Cancer Genetics Program, The Ohio State University,...
|
|
|
NYU Langone Medical Center awarded NIH grants totaling $1,560,000
2 NYU Langone Medical Center researchers receive funding in support of pilot demonstration projects New York, NY, June 24, 2009 Two NYU Langone Medical Center researchers have received $1,560,000 in grant support for their first year of...
|
|
|
Cutaneous Malignancies Among HIV-Infected Persons
Archives of Internal Medicine, 06/23/09 Print Save in My Library Free Abstract Crum-Cianflone N et al.- At present, the most common cutaneous malignancies among HIV-infected persons are NADCs. Cutaneous NADCs do not appear to be...
|
